INNOVUS PHARMACEUTICALS, INC. Cash, Period Increase (Decrease)
INNOVUS PHARMACEUTICALS, INC. reported Cash, Period Increase (Decrease) of -$293.00 thousand for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-14.
Discontinued › Notes
us-gaap:CashPeriodIncreaseDecrease · last filed 2019-11-14
- INNOVUS PHARMACEUTICALS, INC. cash, period increase (decrease) for the quarter ending 2019-09-30 was -$619.00K.
- INNOVUS PHARMACEUTICALS, INC. cash, period increase (decrease) for the quarter ending 2019-06-30 was -$373.00K.
- INNOVUS PHARMACEUTICALS, INC. cash, period increase (decrease) for the quarter ending 2019-03-31 was $699.00K, a 79.19% decline year-over-year.
- INNOVUS PHARMACEUTICALS, INC. cash, period increase (decrease) for the quarter ending 2018-12-31 was $545.00K.
- INNOVUS PHARMACEUTICALS, INC. cash, period increase (decrease) for fiscal 2018 was -$317.00K, a 143.13% decline from fiscal 2017.
- INNOVUS PHARMACEUTICALS, INC. cash, period increase (decrease) for fiscal 2017 was $735.00K.
| Period end | Cash, Period Increase (Decrease) 3 month | Cash, Period Increase (Decrease) 6 month | Cash, Period Increase (Decrease) 9 month | Cash, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2019-09-30 | -$619.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$992.00K derived: sum of 2 quarters · filed 2019-11-14 | -$293.00K 10-Q · filed 2019-11-14 | $252.00K derived: sum of 4 quarters · filed 2019-11-14 |
| 2019-06-30 | -$373.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $326.00K 10-Q · filed 2019-08-13 | $871.00K derived: sum of 3 quarters · filed 2019-08-13 | -$41.00K derived: sum of 4 quarters · filed 2019-11-14 |
| 2019-03-31 | $699.00K 10-Q · filed 2019-05-15 | $1.24M derived: sum of 2 quarters · filed 2019-05-15 | $332.00K derived: sum of 3 quarters · filed 2019-11-14 | -$2.98M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-12-31 | $545.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$367.00K derived: sum of 2 quarters · filed 2019-11-14 | -$3.68M derived: sum of 3 quarters · filed 2019-11-14 | -$317.00K 10-K · filed 2019-04-01 |
| 2018-09-30 | -$912.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$4.22M derived: sum of 2 quarters · filed 2019-11-14 | -$862.00K 10-Q · filed 2019-11-14 | |
| 2018-06-30 | -$3.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $50.00K 10-Q · filed 2019-08-13 | ||
| 2018-03-31 | $3.36M 10-Q · filed 2019-05-15 | |||
| 2017-12-31 | $735.00K 10-K · filed 2019-04-01 |